Literature DB >> 24131186

TREM2 and neurodegenerative disease.

Priya Rajagopalan, Derrek P Hibar, Paul M Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24131186      PMCID： PMC4024453          DOI： 10.1056/NEJMc1306509

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Authors:  Trey Sunderland; Gary Linker; Nadeem Mirza; Karen T Putnam; David L Friedman; Lida H Kimmel; Judy Bergeson; Guy J Manetti; Matthew Zimmermann; Brian Tang; John J Bartko; Robert M Cohen
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

2.  Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.

Authors:  Xue Hua; Derrek P Hibar; Christopher R K Ching; Christina P Boyle; Priya Rajagopalan; Boris A Gutman; Alex D Leow; Arthur W Toga; Clifford R Jack; Danielle Harvey; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2012-11-12       Impact factor: 6.556

3.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

4.  TREM2 is associated with the risk of Alzheimer's disease in Spanish population.

Authors:  Bruno A Benitez; Breanna Cooper; Pau Pastor; Sheng-Chih Jin; Elena Lorenzo; Sebastian Cervantes; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2013-02-05       Impact factor: 4.673

5.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245
  5 in total
  27 in total

1.  Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.

Authors:  Elkin O Luis; Sara Ortega-Cubero; Isabel Lamet; Cristina Razquin; Carlos Cruchaga; Bruno A Benitez; Elena Lorenzo; Jaione Irigoyen; Maria A Pastor; Pau Pastor
Journal:  Neurobiol Aging       Date:  2014-06-17       Impact factor: 4.673

Review 2.  Whole-genome analyses of whole-brain data: working within an expanded search space.

Authors:  Sarah E Medland; Neda Jahanshad; Benjamin M Neale; Paul M Thompson
Journal:  Nat Neurosci       Date:  2014-05-27       Impact factor: 24.884

Review 3.  Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Michael C Donohue; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Paul M Thompson; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

4.  Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.

Authors:  Clifford R Jack; Josephine Barnes; Matt A Bernstein; Bret J Borowski; James Brewer; Shona Clegg; Anders M Dale; Owen Carmichael; Christopher Ching; Charles DeCarli; Rahul S Desikan; Christine Fennema-Notestine; Anders M Fjell; Evan Fletcher; Nick C Fox; Jeff Gunter; Boris A Gutman; Dominic Holland; Xue Hua; Philip Insel; Kejal Kantarci; Ron J Killiany; Gunnar Krueger; Kelvin K Leung; Scott Mackin; Pauline Maillard; Ian B Malone; Niklas Mattsson; Linda McEvoy; Marc Modat; Susanne Mueller; Rachel Nosheny; Sebastien Ourselin; Norbert Schuff; Matthew L Senjem; Alix Simonson; Paul M Thompson; Dan Rettmann; Prashanthi Vemuri; Kristine Walhovd; Yansong Zhao; Samantha Zuk; Michael Weiner
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

Review 5.  Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.

Authors:  Andrew J Saykin; Li Shen; Xiaohui Yao; Sungeun Kim; Kwangsik Nho; Shannon L Risacher; Vijay K Ramanan; Tatiana M Foroud; Kelley M Faber; Nadeem Sarwar; Leanne M Munsie; Xiaolan Hu; Holly D Soares; Steven G Potkin; Paul M Thompson; John S K Kauwe; Rima Kaddurah-Daouk; Robert C Green; Arthur W Toga; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

Review 6.  Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.

Authors:  Richard A Hickman; Arline Faustin; Thomas Wisniewski
Journal:  Neurol Clin       Date:  2016-08-04       Impact factor: 3.806

7.  The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia.

Authors:  Panos Roussos; Pavel Katsel; Peter Fam; Weilun Tan; Dushyant P Purohit; Vahram Haroutunian
Journal:  Alzheimers Dement       Date:  2014-12-09       Impact factor: 21.566

8.  Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.

Authors:  Florence F Roussotte; Boris A Gutman; Sarah K Madsen; John B Colby; Paul M Thompson
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

Review 9.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

10.  Coding variants in TREM2 increase risk for Alzheimer's disease.

Authors:  Sheng Chih Jin; Bruno A Benitez; Celeste M Karch; Breanna Cooper; Tara Skorupa; David Carrell; Joanne B Norton; Simon Hsu; Oscar Harari; Yefei Cai; Sarah Bertelsen; Alison M Goate; Carlos Cruchaga
Journal:  Hum Mol Genet       Date:  2014-06-04       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.